ALX Oncology Holdings Inc.
ALXONASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $135.64M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.89$2.66
- Volume (live)
- -
- Avg. volume (3M)
- 1.42M
ALX Oncology Holdings (ALXO) Stock Price & Financial Analysis
ALX Oncology Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.93 - $1.16 |
|---|---|
| 52-Week High | $2.66 |
| 52-Week Low | $0.89 |
| Open | $1.00 |
| Volume (last close) | 2.43M |
| Average Volume (3M) | 1.42M |
| 50-Day MA | $1.72 |
|---|---|
| 200-Day MA | $1.83 |
| 1-Year Change | −33.33% |
| Market Cap | 135.64M |
|---|---|
| Shares Outstanding | 135.64M |
| Price to Book (P/B) | 1.00 |
| EV/EBITDA | -1.55 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
ALX Oncology Holdings at a Glance
As of the Oct 16, 2026 close, ALX Oncology Holdings (ALXO) has a market capitalization of $135.64M.
As of its latest reported balance sheet, it holds $22.69M in cash and securities against $9.71M of debt, a net cash position of $12.98M.
ALX Oncology Holdings does not currently pay a dividend.
The share price is down 33.3% over the past year. At $1.06 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.89 to $2.66, below its 200-day moving average of $1.83.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $4.33, 308.5% above the Oct 16, 2026 close.
Frequently Asked Questions About ALX Oncology Holdings
What is the current stock price for ALXO?
As of the Oct 16, 2026 close, ALXO stock trades at $1.06. The 52-week range is $0.89–$2.66, with a day range of $0.93–$1.16.
What is the P/E ratio for ALXO?
The P/E ratio (Price-to-Earnings) for ALXO is shown in the Key Statistics section. This valuation metric helps compare ALX Oncology Holdings Inc. to industry peers.
Does ALXO pay dividends?
ALX Oncology Holdings does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for ALXO?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for ALXO is Buy. The average 12-month price target is $4.33, a 308.5% upside from the Oct 16, 2026 close of $1.06.
What is the market cap of ALXO?
As of the Oct 16, 2026 close, ALX Oncology Holdings's market capitalization is $143.8M, classifying it as a micro-cap company. ALX Oncology Holdings operates in the Healthcare sector within the Biotechnology industry.